Table 3 Prevalence of Individual FCI Comorbidities by Data Collection Method (n = 421)
From: The functional comorbidity index had high inter-rater reliability in patients with acute lung injury
FCI Comorbidity, n (%) | Prospective: Admission Records | Retrospective: Discharge Summaries | p-value* |
|---|---|---|---|
Arthritis (rheumatoid and osteoarthritis) | 4 (1) | 23 (5) | <0.01 |
Osteoporosis | 4 (1) | 10 (2) | 0.03 |
Asthma | 16 (4) | 28 (7) | <0.01 |
COPD, emphysema, or ARDS | 21 (5) | 56 (13) | <0.01 |
Angina | 1 (1) | 1 (1) | 1.00 |
Congestive heart failure (or heart disease) | 80 (19) | 84 (20) | 0.07 |
Myocardial infarction | 24 (6) | 13 (3) | 0.03 |
Neurological disease (e.g., MS or Parkinson’s) | 7 (2) | 55 (13) | <0.01 |
Stroke or TIA | 34 (8) | 25 (6) | 0.32 |
Peripheral vascular disease | 13 (3) | 25 (6) | <0.01 |
Diabetes type I or II | 105 (25) | 81 (19) | 0.74 |
Upper GI disease (e.g., ulcer, hernia, reflux) | 26 (6) | 77 (18) | <0.01 |
Depression | 39 (9) | 62 (15) | <0.01 |
Anxiety or panic disorders | 7 (2) | 22 (5) | <0.01 |
Visual impairment (e.g., cataracts, glaucoma) | 2 (1) | 9 (2) | <0.01 |
Hearing impairment (e.g., hard of hearing with aids) | 1 (1) | 1 (1) | 0.32 |
Degenerative disc disease (e.g., spinal stenosis) | 8 (2) | 14 (3) | 0.01 |
FCI Score, median (IQR)** | 1 (0–2) | 2 (1–3) | <0.01 |